Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Three Arch Sticks to its Knitting

This article was originally published in Start Up

Executive Summary

Three Arch Partners recently raised $400 million in less than a month's time, creating probably the largest pool of venture capital dedicated to medical devices. The fund came together quickly, through existing limited partners. Three Arch told existing investors that it planned to do exactly what has made it successful in the past: focus on medical devices with a smattering of selected services, dedicating a majority of the fund-perhaps 70%--to early stage investments. For investors who have been with Three Arch through its past funds, that works.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel